Abu Dhabi Diabetes and Obesity Study
1 other identifier
observational
2,130
1 country
1
Brief Summary
A cross-sectional study investigating the aetiology, mechanisms and associated complications contributing to obesity and diabetes within the UAE population. The study will be carried out in two main sample populations; children and adults, and characterized by the occurrence of obesity and diabetes. The main samples will then be divided into a subgroup for metabolomic analysis. Patients will be recruited from the Imperial College London Diabetes Centre. The study is aimed at elucidating the various factors that have an impact or may influence obesity and diabetes in the Emirati population.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2013
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2013
CompletedFirst Submitted
Initial submission to the registry
April 25, 2013
CompletedFirst Posted
Study publicly available on registry
May 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2017
CompletedOctober 13, 2021
October 1, 2021
4.1 years
April 25, 2013
October 5, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Percentage of the population in the U.A.E that are positive for adenovirus -36, specifically in children.
The initial aim of the study is to measure the prevalence of adenovirus 36 in the Emirati population.
One year
Study Arms (1)
Emirati Population
The individuals enrolled in this study will be divided into children (5-16 years of age) and adults (above 18). The groups will be further divided into BMI categories and glucose tolerance groups. \* Group 1: Underweight (adjusted BMI \<10th percentile) and no diabetes * Group 2: Normal weight (adjusted BMI 10th to 84.9th percentile) and no diabetes * Group 3: Overweight or obese children (adjusted BMI \>= 85th percentile) and no diabetes * Group 4: Normal weight (adjusted BMI 10th to 84.9th percentile) and T1DM * Group 5: Overweight or obese children (adjusted BMI ≥ 85th percentile) and T1DM * Group 6: Normal weight (adjusted BMI 10th to 84.9th percentile) and T2DM * Group 7: Overweight or obese children (adjusted BMI ≥ 85th percentile) and T2DM
Eligibility Criteria
Patients from the Imperial College London Diabetes Centre, Abu Dhabi.
You may qualify if:
- All patients are eligible to participate in the study
You may not qualify if:
- Under 5 years of age
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Imperial College London Diabetes Centre
Abu Dhabi, 48338, United Arab Emirates
Related Publications (2)
Almgren M, Atkinson R, He J, Hilding A, Hagman E, Wolk A, Thorell A, Marcus C, Naslund E, Ostenson CG, Schalling M, Lavebratt C. Adenovirus-36 is associated with obesity in children and adults in Sweden as determined by rapid ELISA. PLoS One. 2012;7(7):e41652. doi: 10.1371/journal.pone.0041652. Epub 2012 Jul 27.
PMID: 22848557BACKGROUNDAtkinson RL. Adenovirus-36 and obesity. Pediatr Obes. 2012 Apr;7(2):e18-9. doi: 10.1111/j.2047-6310.2011.00043.x. No abstract available.
PMID: 22434760BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Consultant Endocrinologist
Study Record Dates
First Submitted
April 25, 2013
First Posted
May 1, 2013
Study Start
March 1, 2013
Primary Completion
April 1, 2017
Study Completion
April 1, 2017
Last Updated
October 13, 2021
Record last verified: 2021-10